A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 206
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : Gd-EOB-DTPA
Long Form : gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid
No. Year Title Co-occurring Abbreviation
2019 A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria. AFP, DCP, HCC, MRI, MVI, OR
2019 Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase. CP, MELD, MRI
2019 Chinese consensus on the clinical application of hepatobiliary magnetic resonance imaging contrast agent: Gadoxetic acid disodium. MRI
2019 Conspicuity of Malignant Liver Tumors on Diffusion-Weighted Imaging With Short tau Inversion Recovery After Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid Administration. CHESS, CNR, DWI, STIR
2019 Establishment and Characterization of a New Cell Line Permissive for Hepatitis C Virus Infection. HCV, miR-122
2019 Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis. DCE-MRI, HFD, NAS, NASH, RE, SD, Tmax, WT
2019 Four-dimensional fully convolutional residual network-based liver segmentation in Gd-EOB-DTPA-enhanced MRI. CAD, FC-ResNet, MRI
2019 Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. HBP, HCC, MRI
2019 Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patients. CNR, MRI, PBC, RE
10  2019 Longitudinal Visualization of Viable Cancer Cell Intratumoral Distribution in Mouse Models Using Oatp1a1-Enhanced Magnetic Resonance Imaging. BLI, MRI, Oatp1a1
11  2019 Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy. FLR, HPB
12  2019 The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies. CE-MDCT, HCC, MRI, SROC
13  2019 Usefulness of Gd-EOB-DTPA-enhanced MRI for evaluating the potential for early development of hepatocellular carcinoma after HCV eradication by direct-acting antiviral treatment. DAA, HCC, MRI, SVR
14  2018 Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm. IPMN, MRI
15  2018 Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B. AFP, AUC, CHB, CV, HCC, LC, MR, ROC
16  2018 Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase. MR
17  2018 Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences. MELD
18  2018 Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma. CT, DCE-MRI, HCC, MDCT
19  2018 Hepatic Angiomyolipoma Staining in the Post-vascular Phase of Contrast-enhanced Ultrasound Due to the Presence of Macrophages. CD, CEUS, HAML, HCC
20  2018 Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla. HBP, HBV, LPC, ROC
21  2018 Morphological classification of intraductal papillary neoplasm of the bile duct. CT, IPMN-B, IPNB, IPNB-NM, MRI, PET-CT
22  2018 New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. AASLD, HCC, HGDNs
23  2018 Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging. AUC, CHB/C, HeF, MRI, Re
24  2018 Targeting Accuracy of Image-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Real-Life Clinical Practice: InVivo Assessment Using Hepatic Parenchymal Changes on Gd-EOB-DTPA-Enhanced Magnetic Resonance Images. HCC, ICD, IQR, MR, SBRT
25  2018 [Gadolinium Ethoxybenzyl Diethylene-triamine-pentaacetic-acid-enhanced Magnetic Resonance Imaging Perfusion and Multiple Hepatobiliary-phase Imaging for Quantitative Assessment of Liver Fibrosis in Rat Models]. MRI, Tmax, Ve
26  2017 3D T2-weighted and Gd-EOB-DTPA-enhanced 3D T1-weighted MR cholangiography for evaluation of biliary anatomy in living liver donors. T1w-MRC, T2w-MRC
27  2017 Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis. CEI, MRE, MRI, RE
28  2017 Comparison of the Timing of Hepatic Arterial Phase and Image Quality Using Test-Bolus and Bolus-Tracking Techniques in Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced Hepatic Dynamic Magnetic Resonance Imaging. HAP, MRI
29  2017 Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study. ADC, CLMs, DW, NAC, TBR, TV
30  2017 Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A Comparative Study with Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced Computed Tomography (CT). AUC, CT, DCEMRI, HB, HCC, MRI, ROC
31  2017 Diagnostic value of Gd-EOB-DTPA-enhanced MR cholangiography in non-invasive detection of postoperative bile leakage. DP, HBP, MRC, T1W, T2W
32  2017 Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry. HUI, ICG, MR, SI
33  2017 Image Non-Uniformity Correction for 3-T Gd-EOB-DTPA-Enhanced MR Imaging of the Liver. CER, LMR, LSR, MR, PURE, SCIC
34  2017 Influence of Indocyanine Green on Hepatic Gd-EOB-DTPA Uptake: A Proof-of-Concept Study in Mice. CRs, ICG
35  2017 Influence of the Magnetic Field Strength on Image Contrast in Gd-EOB-DTPA-enhanced MR Imaging: Comparison between 1.5T and 3.0T. CER, LMR, LSR, MR
36  2017 Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: A preliminary study comparing with 99mTc GSA scintigraphy and signal intensity based parameters. ICG, LMR, LSR, MR, RE, ROC, SI
37  2017 Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma. HCC, IDR, RFA
38  2017 Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma. HCC, MRI, RFA
39  2017 Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dynamic CT for Detecting Recurrence of HCC after Radiofrequency Ablation. AUROC, HCC, MDCT, MRI, RFA
40  2017 TWIST-VIBE five-arterial-phase technology decreases transient severe motion after bolus injection of Gd-EOB-DTPA. Gd-DTPA, MRI, TSM, TWIST
41  2016 A case of idiopathic portal hypertension associated with nodular regenerative hyperplasia-like nodule of the liver and mixed connective tissue disease. FNH, MCTD, NRH
42  2016 A case of unresectable combined hepatocellular cholangiocarcinoma showing favorable response to LFP therapy. MRI
43  2016 A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images. FLR, MRI, SABR, TD
44  2016 Balanced MR cholangiopancreatography with motion-sensitised driven-equilibrium (MSDE) preparation: feasibility of Gd-EOB-DTPA-enhanced biliary examination. CNR, HV, MPD, MRCP, MSDE, PV
45  2016 Biochemical and Clinical Predictive Approach and Time Point Analysis of Hepatobiliary Phase Liver Enhancement on Gd-EOB-DTPA-enhanced MR Images: A Multicenter Study. LLC, LSC, MR, PT
46  2016 Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma. AUC, CEUS, HCC, SN
47  2016 Distinguishing liver haemangiomas from metastatic tumours using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced diffusion-weighted imaging at 1.5T MRI. CNRs, DWI, IVIM, METs
48  2016 Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging. ---
49  2016 Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration. HBP, IP, MR, NETLM, OOP
50  2016 Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice. AST, MCD, NASH, RE, Tmax
51  2016 Hepatic enhancement of Gd-EOB-DTPA-enhanced 3 Tesla MR imaging: Assessing severity of liver cirrhosis. CEI, HP
52  2016 Hepatic Hemangiomas: Factors Associated with Pseudo Washout Sign on Gd-EOB-DTPA-enhanced MR Imaging. MR, PWS
53  2016 Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma. CT, HCC, MR, SBRT
54  2016 Hepatobiliary phase images using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI as an imaging surrogate for the albumin-bilirubin grading system. ALBI, CP, HBP, Q-LSC
55  2016 Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study. HR, US
56  2016 The Impact of Gd-Eob-Dtpa-Enhanced MR Cholangiography in Biliary Diseases: Comparison with T2-Weighted MR Cholangiopancreatography. MRC, MRCP
57  2015 Characterization of the biliary tract by virtual ultrasonography constructed by gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. MRI, RFA
58  2015 Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver. LSM, MRI, ROC, RR, T1-RT
59  2015 Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules. DWI, HCC, MRI
60  2015 Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography. CI, CMN, CT, HCC, MRI, SN, SN-EG
61  2015 Diagnostic confidence of computed tomography and magnetic resonance in focal liver pathology. AUC, CI, CT, MR
62  2015 Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats. AUROC, DCE-MRI, RE
63  2015 Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid. DP, ER, Gd-DTPA, HP, MRI, VP
64  2015 Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging and Multidetector-Row Computed Tomography for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. HCC, MDCT, MRI
65  2015 Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging: A potential utility for the evaluation of regional liver function impairment following transcatheter arterial chemoembolization. MRI, SNR, TACE
66  2015 Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a useful detection method for advanced primary biliary cirrhosis. MRI, OATP1B3, PBC, RE
67  2015 Gd-EOB-DTPA-enhanced and diffusion-weighted magnetic resonance findings in hepatic epithelioid angiomyolipoma: A case report. MRI
68  2015 Gd-EOB-DTPA-enhanced magnetic resonance imaging for bile duct intraductal papillary mucinous neoplasms. CT, IPMN-B, MRI
69  2015 Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation. RE, VIBE
70  2015 Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC. BCLC, HCC, MRI
71  2015 Respiratory Motion-Resolved Compressed Sensing Reconstruction of Free-Breathing Radial Acquisition for Dynamic Liver Magnetic Resonance Imaging. VIBE, XD-GRASP
72  2015 Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol. CT, HCC, MR
73  2015 Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS). Gd, ICP-MS
74  2014 Accumulation of Bile in the Gallbladder: Evaluation by means of Serial Dynamic Contrast-Enhanced Magnetic Resonance Cholangiography with Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid. ---
75  2014 Can biliary-cyst communication be predicted by Gd-EOB-DTPA-enhanced MR cholangiography before treatment for hepatic hydatid disease? BCC, GRE, HHD, MRC
76  2014 Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid. ---
77  2014 Clinical utility of imaging for evaluation of hepatocellular carcinoma. Gd-DTPA, HCC, MDCT, MR
78  2014 Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma. HCC, MRI
79  2014 Co-registered positron emission tomography/computed tomography and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging features of multiple angiosarcoma of the liver. CT, FDG-PET, MRI
80  2014 Coexpression of organic anion-transporting polypeptides 1B3 and multidrug-resistant proteins 2 increases the enhancement effect of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid on hepatocellular carcinoma in magnetic resonance imaging. HCC, MRI, MRP, OATP, RER
81  2014 Detection and localization of bile duct leaks after cholecystectomy using Gd-EOB-DTPA-enhanced MR cholangiography: retrospective study of 16 patients. MR
82  2014 Effect of Gd-EOB-DTPA on hepatic fat quantification using high-speed T2-corrected multi-echo acquisition in (1)H MR spectroscopy. FF, HISTO, ICC, MRS
83  2014 Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function. ICG
84  2014 Functional magnetic resonance cholangiography enhanced with Gd-EOB-DTPA: effect of liver function on biliary system visualization. CBD, MELD, rSI
85  2014 Functional magnetic resonance cholangiography with Gd-EOB-DTPA: a study in healthy volunteers. CBD, GB, GBEF, IHDs, MRC, POFM, PRFM
86  2014 Gadoxetic acid disodium (Gd-EOBDTPA)-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis. CI, DOR, HCC, MRI, NLR, PLR, QUADAS, SEN, SPE, SROC
87  2014 Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. AFP, EOB-MRI, HCC, MRI
88  2014 Impaired hepatic Gd-EOB-DTPA enhancement after radioembolisation of liver malignancies. MRI, RE
89  2014 Infantile hemangioma of the liver in an adult: a case report and review of the literature. ADC, CT, IH
90  2014 MR imaging of carcinosarcoma of the liver using Gd-EOB-DTPA. ---
91  2014 Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI. AP, CER, HP, LLC, LP, MR, MRI, PVP, SI, SNR
92  2014 Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices. CP-B, CPA, ICG, MRI, NLF
93  2014 Radial MRI during free breathing in contrast-enhanced hepatobiliary phase imaging. MRI, SE, TIGRE
94  2014 Volume change and liver parenchymal signal intensity in Gd-EOB-DTPA-enhanced magnetic resonance imaging after portal vein embolization prior to hepatectomy. CT, MRI, PVE, SIs
95  2013 A simple and inexpensive system for controlling body temperature in small animal experiments using MRI and the effect of body temperature on the hepatic kinetics of Gd-EOB-DTPA. AUC, DCE-MRI, MRI, tmax
96  2013 Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol. AFF, DCE-MRI, ROIs, UR, VE
97  2013 Biliary peritonitis after radiofrequency ablation diagnosed by gadoxetic acid-enhanced MR imaging. MR
98  2013 Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis. MELD, MR, RE, SI
99  2013 Comparison of acquired diffusion weighted imaging and computed diffusion weighted imaging for detection of hepatic metastases. DWI, MRI, ROC, T1WI, T2WI
100  2013 Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA. DCE-MRI, EHBRs, MRP2, Oatp1